Search - tctmd.com

Displaying 121 - 140 of 161

Sort: Relevancy | Date

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Stuart Watkins

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

Case #2: Multivessel Disease in an NSTEMI Patient

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Keith G. Oldroyd

September 14, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

Presentation TCT 2013

The Conundrum of Switching DAPT

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

Critical Appraisal and Clinical Implications(3)

Presenter: Dean Kereiakes

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Presentation TCT 2013

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Presenter: Dean Kereiakes

October 29, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

Presentation TCT 2012

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Presenter: Dean Kereiakes

October 25, 2012

Advertisement

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #3. Multivessel Disease in a Stable CAD Patient

How Did I Treat This Patient?

Case #2: Multivessel Disease in an NSTEMI Patient

How Did I Treat This Patient?

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

The Conundrum of Switching DAPT

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Critical Appraisal and Clinical Implications(3)

OPTIMIZE: 3-Month DAPT Safe with ZES

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

Abbott Initiates Clinical Trial of Absorb™ in the United States

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content